Literature DB >> 7692521

Variations in affinities for the NK1 receptor: differences between the non-peptide substance P antagonists RP 67580 and CP-96,345 and the agonist septide.

V Fardin1, F Foucault, M D Bock, A Jolly, O Flamand, F Clerc, C Garret.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692521     DOI: 10.1016/0167-0115(93)90066-h

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


× No keyword cloud information.
  6 in total

1.  Central versus peripheral site of action of the tachykinin NK1-antagonist RP 67580 in inhibiting chemonociception.

Authors:  U Holzer-Petsche; T Rordorf-Nikolić
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

2.  Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.

Authors:  J Culman; B Wiegand; H Spitznagel; S Klee; T Unger
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

3.  Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Authors:  O Piot; J Betschart; I Grall; S Ravard; C Garret; J C Blanchard
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

4.  Demonstration of a 'septide-sensitive' inflammatory response in rat skin.

Authors:  A Ahluwalia; S Giuliani; C A Maggi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

5.  Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.

Authors:  A Floch; V Fardin; I Cavero
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

6.  Effects of RP 67580, a tachykinin NK1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord.

Authors:  R Hosoki; M Yanagisawa; J Z Guo; K Yoshioka; T Maehara; M Otsuka
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.